Abstract

A STUDY TO EVALUATE THE ROLE OF PHARMACEUTICAL CARE ON QUALITY OF LIFE (QOL) IN PATIENTS WITH HYPERTENSION IN A TERTIARY CARE TEACHING HOSPITAL, DAVANAGERE

Dr. Santosh Uttangi*, Prof. J. S. Venkatesh*, Anjali Maria Thomas*, Aadithya*, Akhila K. R.* and Anagha T. J.*

Abstract

Background: Hypertension is the most important modifiable risk factor for all cause of morbidity and mortality worldwide. Pharmaceutical care optimizes the patient’s Quality of Life (QOL) which includes several factors that are effective in preventing hypertension. Objectives: The objective of the study was to evaluate the role of pharmaceutical care on QOL in patients with hypertension. Methodology: A prospective observational study was carried out for a period of six months in both inpatients and outpatients of the medicine department of Chigateri District Hospital, Davangere. Results: A total of 200 patients were enrolled, the majority, 58% were males. Most of the patients were of age group of 40-60 years, 90% were married, 68.5% had healthy weight, 67% without family history, 25% were smokers, 27% of diabetic mellitus as major comorbidity. When control group compared with intervention group, 22% and 40% patients experienced adverse drug reactions and drug interaction as major drug related problems. On medication history review, intervention group received 62% of prescription drugs. Overall self-care practise level was good in 58% of hypertensive patients. In SF36, intervention group had higher scores of physical component summary and mental component summary compared to control group. WHOQOL-BREF showed intervention group has higher scores of physical health, psychological health, social relationship and environment compared to control group. Conclusion: The study concluded that patients in the intervention group achieved more positive outcomes than the patients in control group. Pharmaceutical care contributed to increase the QOL of patients.

Keywords: Pharmaceutical care, Quality of life, Hypertension.